The value of patents to biotechnology innovation cannot be understated. They enable innovators time to recoup the massive development costs of a new biotech product. Strong intellectual property measures are necessary to advance biotechnology innovation, the creation of high-wage, high-value jobs, and the ability to bring life-saving treatments and cures to market.
BIO Toolkit Resources
In the public debate over drug costs, there is a lot of discussion about so-called “evergreening.”
BIO Comments on Patent Policy
- BIO Submits Comments to the USPTO on Discretion to Institute Trials Before the Patent Trial and Appeal Board
- BIO’s Comments on PTAB Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial Evidence
- BIO’s Comments on Improvements to Claim Amendment Process in inter partes and post-grant review proceedings
- BIO’s Comments on Revised Patent Subject Matter Eligibility Guidance
- BIO’s Comments on Claim Construction Standards in post-grant review proceedings
- BIO’s Comments on Motion to Amend Practice and Procedures in AIA Trials
- BIO’s Comments on Determining Whether a Claim Element Is Well-Understood, Routine, Conventional for Purposes of Subject Matter Eligibility
- BIO’s Comments on the Revision of the Duty To Disclose Information in Patent Applications and Reexamination Proceedings

Become an Advocate for Biotechnology
Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.